Clearance Summary
CEFAR MEDICAL AB CEFAR PRIMO received FDA 510(k) clearance under submission number K020803, sponsored by Cefar Medical AB. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2002-06-10.
- Submission: K020803
- Applicant / Sponsor: Cefar Medical AB
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5890
- Decision date: 2002-06-10
Classification & Regulation
This clearance is catalogued under FDA product code GZJ and 21 CFR 882.5890, within the Neurology review panel as a Class II device.